|
Volumn 23, Issue 13, 2013, Pages 3891-3895
|
Discovery of a small molecular compound simultaneously targeting RXR and HADC: Design, synthesis, molecular docking and bioassay
|
Author keywords
Anti cancer; Dual target; Histone deacetylase; Retinoid X receptors
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HISTONE DEACETYLASE;
HISTONE DEACETYLASE INHIBITOR;
HYDROXAMIC ACID DERIVATIVE;
RECEPTOR BLOCKING AGENT;
RETINOID DERIVATIVE;
RETINOID X RECEPTOR;
ANTINEOPLASTIC ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
ARTICLE;
BIOASSAY;
CANCER CELL CULTURE;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG SYNTHESIS;
DRUG TARGETING;
FEMALE;
HUMAN;
HUMAN CELL;
IC 50;
MOLECULAR DOCKING;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL PROLIFERATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DISCOVERY;
DRUG SCREENING ASSAYS, ANTITUMOR;
HELA CELLS;
HISTONE DEACETYLASES;
HL-60 CELLS;
HUMANS;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
RETINOID X RECEPTORS;
SMALL MOLECULE LIBRARIES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84878875803
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2013.04.067 Document Type: Article |
Times cited : (19)
|
References (17)
|